Loading…
Tuesday September 29, 2026 11:30 - 12:15 CEST
Key success factors behind high-performing spin-offs, including team, science, funding strategy and execution. What to take into account in the early stages to move fast, de-risk projects and build strong foundations for growth. Insights and lessons learned from real cases and different stakeholder perspectives.
Moderators
avatar for Anna Bellmunt

Anna Bellmunt

Senior Associate, Asabys Partners
Senior Associate at Asabys, where she joined in 2021, Anna is responsible for sourcing and assessing opportunities from the scientific, development and business perspectives. Anna currently serves as a board observer at Ona Therapeutics and Nuage Therapeutics.Previously, Anna was... Read More →
Speakers
avatar for Agnés Arbat

Agnés Arbat

Spanish biotech founder, Oxolife

avatar for Gustavo Fuster

Gustavo Fuster

IP lawyer, Hoffmann Eitle
Gustavo Fúster is a patent professional with over 15 years of experience within the field of life sciences patents.

Gustavo first worked as an in-house IP manager and patent specialist in a Spanish biotech firm which provided him with experience in the field of monoclonal antibod

... Read More →
avatar for Etienne Drouet

Etienne Drouet

Vice President, Client Partner & Adviser for Biotech & Venture Capitals, IQVIA
33 years experience in Drug Development in Pharmaceutical industry, Biotech, Contract Research Organisation and Investigational Cooperative Groups.

Specialties: 
- Drug Development in Biotechnology, Oncology, precision medicine & gene therapy, Early Phase Development,
- Project Man



... Read More →
avatar for Marcos Simón

Marcos Simón

Head of TTO, CIC Biomagune

Tuesday September 29, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

Attendees (1)


Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link